Hair loss drug shows long-term sexual side effects

July 23, 2012
Hair loss drug shows long-term sexual side effects
For men with finasteride-associated side effects, sexual dysfunction may persist for months or years, even after discontinuation of the drug, according to a study published online July 12 in The Journal of Sexual Medicine.

(HealthDay) -- For men with finasteride-associated side effects, sexual dysfunction may persist for months or years, even after discontinuation of the drug, according to a study published online July 12 in The Journal of Sexual Medicine.

Michael S. Irwig, M.D., of George Washington University in Washington, D.C., conducted a prospective study involving 54 young men (mean age, 26 years) with persistent -associated side effects to examine whether the persistent sexual side effects resolve or endure over time. The Arizona Scale (ASEX) was used to measure sexual dysfunction.

The author noted a participation rate of 81 percent. At reassessment (mean 14 months), persistent side effects were still present in 96 percent of participants, and 89 percent met the definition for sexual dysfunction according to the ASEX criteria. Changes in the scores of sexual dysfunction were not affected by the length of finasteride use or the duration of the sexual side effects.

"Men who developed persistent sexual and other side effects lasting for at least three months after discontinuing finasteride continue to have a high prevalence of for subsequent months or years," the author writes. "It is recommended that prescribers of finasteride, as well as potential users, be aware of the potential serious long-term risks of a medication used for a cosmetic purpose."

Explore further: Study finds link between relationship style and sexual dysfunction

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Study finds link between relationship style and sexual dysfunction

March 7, 2012
(Medical Xpress) -- Deakin University research has shown that being too needy or not needy enough in a relationship can result in sexual issues.

Baldness drug may cause sexual side effects: FDA

April 12, 2012
(HealthDay) -- Two Merck & Co. drugs -- one to treat hair loss in men, the other to treat an enlarged prostate gland -- will get revised labels warning of potential sexual side effects that can last even after patients stop ...

Most women on dialysis may experience sexual problems

April 5, 2012
The vast majority of female kidney failure patients on dialysis may experience sexual problems, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). Additional ...

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.